García-Morillo J S, Bernabeu-Wittel M, Ollero-Baturone M, González de la Puente M A, Cuello-Contreras J A
Unidad Clínica de Atención Médica Integral, Servicio de Medicina Interna, Hospital Universitario Virgen del Rocío, Sevilla, España.
Rev Clin Esp. 2007 Jan;207(1):1-5. doi: 10.1157/13098491.
Incidence, clinical features, and outcome of heart failure in patients with other chronic pathologies have been scarcely evaluated. The aim of the present study was to prospectively assess these issues, and the prognostic and factors associated to functional deterioration in a cohort of pluripathologic patients (PP) with heart failure (HF), attended in areas of Internal Medicine of a tertiary teaching hospital in the south of Spain.
Prospective observational study of all patients, attended in Internal Medicine areas of a tertiary teaching hospital, during June 2003. Patients were stratified in two cohorts: PP with HF as main category (PP-HF), and PP with no HF. Patients with two or more chronic diseases, distributed into seven categories (defined by a panel of experts) were considered PP. Incidence of PP-HF, functional evaluation (at baseline, at admission, and at discharge), and burden of hospital care (by means of urgent and programmed assistances, as well as episodes of hospitalization) in the last 12 months were analyzed. Chi-square, Fisher, "t" Student or U-Mann-Whitney and Rho de Spearman test were used for group comparisons. A multivariate analysis of predictors of survival and functional deterioration (fall in Barthel's scale > or = 10 points between baseline-discharge values) was performed in the PP-HF cohort. A p < 0.05 was considered significant.
132 pluripathologic patients (55 in PP-HF, and 77 in PP cohort) were included, from a global cohort of 339. Global incidence of PP-HF was 38,9/100 admissions. Mean age of PP-HF patients was 78, 50.9% were females; mortality rate and mean hospital stay were 23.6% and 12.2 days, respectively. Patients of PP-HF cohort compared to those of PP, were older (78 +/- 9.5 vs 73 +/- 10.8; p < 0.005), and suffered more chronic diseases (p = 0.0001). Functional abilities (at baseline, at admission, and at discharge), mean hospital stay, mortality, and burden of care in the previous 12 months were similar. Better functional abilities (OR: 1.136 [0.94-1.842]; p = 0.055), and less associated chronic diseases (OR: 0.072 [0.006-0.943], p = 0.045) were independently associated to survival; while older age (OR: 1,217 [1.016-1.457]; p = 0.03), and a poorer functional status at baseline (OR:1.80 [1.019-1.144]; p = 0.01) were associated to functional deterioration.
Heart failure prevalent disease in pluripathologic patients. Specific factors associated to survival were gender and less chronic conditions; while those associated to functional deterioration during hospital stay were age and a poor functional status at baseline.
其他慢性疾病患者心力衰竭的发病率、临床特征及预后鲜少得到评估。本研究旨在对西班牙南部一家三级教学医院内科收治的多病理患者(PP)队列中心力衰竭(HF)患者的上述问题,以及功能恶化的预后及相关因素进行前瞻性评估。
对2003年6月在一家三级教学医院内科就诊的所有患者进行前瞻性观察研究。患者被分为两个队列:以心力衰竭为主要类别(PP-HF)的多病理患者,以及无心力衰竭的多病理患者。患有两种或更多种慢性疾病(由专家小组定义)的患者被视为多病理患者。分析了PP-HF的发病率、功能评估(基线、入院时和出院时)以及过去12个月的医院护理负担(通过紧急和计划性援助以及住院次数)。采用卡方检验、费舍尔检验、学生“t”检验或曼-惠特尼U检验以及斯皮尔曼相关系数检验进行组间比较。对PP-HF队列中生存和功能恶化的预测因素(基线至出院时巴氏量表评分下降≥10分)进行多变量分析。p<0.05被认为具有统计学意义。
在339例患者的总队列中,纳入了132例多病理患者(PP-HF组55例,PP队列77例)。PP-HF的总体发病率为38.9/100例入院患者。PP-HF患者的平均年龄为78岁,女性占50.9%;死亡率和平均住院天数分别为23.6%和12.2天。与PP队列患者相比,PP-HF队列患者年龄更大(78±9.5岁 vs 73±10.8岁;p<0.005),患慢性疾病更多(p = 0.0001)。功能能力(基线、入院时和出院时)、平均住院天数、死亡率以及过去12个月的护理负担相似。功能能力较好(比值比:1.136[0.94-1.842];p = 0.055)和慢性疾病较少(比值比:0.072[0.006-0.943],p = 0.045)与生存独立相关;而年龄较大(比值比:1.217[1.016-1.457];p = 0.03)和基线功能状态较差(比值比:1.80[1.019-1.144];p = 0.01)与功能恶化相关。
心力衰竭在多病理患者中是一种常见疾病。与生存相关的特定因素是性别和较少的慢性疾病;而与住院期间功能恶化相关的因素是年龄和基线功能状态差。